Indaptus Therapeutics, Inc. (INDP)
NASDAQ: INDP · Real-Time Price · USD
1.500
+0.090 (6.38%)
Sep 19, 2024, 4:00 PM EDT - Market closed
Indaptus Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Selling, General & Admin | 8.91 | 8.76 | 8.59 | 5.21 | 0.94 | 0.54 |
| Research & Development | 7.57 | 7.62 | 6.32 | 2.52 | 2.66 | 2.09 |
| Operating Expenses | 16.48 | 16.38 | 14.91 | 7.73 | 3.6 | 2.63 |
| Operating Income | -16.48 | -16.38 | -14.91 | -7.73 | -3.6 | -2.63 |
| Other Non Operating Income (Expenses) | 0.73 | 0.96 | 0.59 | 0.02 | 0.02 | 0.07 |
| Pretax Income | -15.75 | -15.42 | -14.32 | -7.71 | -3.58 | -2.57 |
| Net Income | -15.75 | -15.42 | -14.32 | -7.71 | -3.58 | -2.57 |
| Net Income to Common | -15.75 | -15.42 | -14.32 | -7.71 | -3.58 | -2.57 |
| Shares Outstanding (Basic) | 8 | 8 | 8 | 4 | 2 | 1 |
| Shares Outstanding (Diluted) | 8 | 8 | 8 | 4 | 2 | 1 |
| Shares Change (YoY) | 1.37% | 1.68% | 101.98% | 110.35% | 165.44% | - |
| EPS (Basic) | -1.86 | -1.84 | -1.73 | -1.89 | -1.84 | -3.50 |
| EPS (Diluted) | -1.86 | -1.84 | -1.73 | -1.89 | -1.84 | -3.50 |
| Free Cash Flow | -12.75 | -13.41 | -13.08 | -11.29 | -3.32 | -2.13 |
| Free Cash Flow Per Share | -1.51 | -1.60 | -1.58 | -2.76 | -1.71 | -2.91 |
| EBITDA | -16.48 | -16.38 | -14.91 | -7.73 | -3.6 | -2.63 |
| D&A For EBITDA | 0 | 0 | 0 | 0 | 0 | 0 |
| EBIT | -16.48 | -16.38 | -14.91 | -7.73 | -3.6 | -2.63 |
Source: S&P Capital IQ. Standard template.
Financial Sources.